{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"6.300","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"669,512,908","primaryexch":"香港交易所","ric":"9996.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BMT7V13","am":"14.39","iv":"","ew_strike":"","as":"6.130","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"6.100","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"1,000","update_time":"2025-09-28 00:06:03.0","lo52":"2.870","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"張一","underlying_ric":"9996.HK","hi52":"9.360","issuer_name":"沛嘉醫療有限公司 - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"6.090","mkt_cap":"4.10","f_aum_hkd":null,"ew_sub_per_to":"","ls":"6.130","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 其他醫療保健","ew_desc":null,"inception_date":"","nc":"-0.170","aum":"","issued_shares_class_B":null,"vo":"2.34","secondary_listing_flag":false,"listing_date":"2020年5月15日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"沛嘉醫療有限公司 - B","nm_s":"沛嘉醫療－Ｂ","sym":"9996","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"沛嘉醫療有限公司是一家主要提供介入手術醫療器械產品的投資控股公司。該公司主要運營兩個業務分部，經導管瓣膜治療業務分部和神經介入業務分部。經導管瓣膜治療業務分部主要從事研發、製造及銷售經導管瓣膜治療醫療器械業務。神經介入業務分部主要從事研發、製造及銷售神經介入手術醫療器械業務。該公司的產品包括TaurusOne、TaurusElite等商業化產品。該公司主要在中國境內開展業務。","op":"6.300","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"醫療設備及用品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港銅鑼灣<br/>希慎道33號<br/>利園一期<br/>19樓1901室","pc":"-2.70","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"6.300","isin":"KYG6981F1090","moneyness":""}},"qid":"1759074352328"}
